elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27021470-604F05DA-0A9E-4D24-A895-E8A2BD5F633B
Q27021470-604F05DA-0A9E-4D24-A895-E8A2BD5F633B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27021470-604F05DA-0A9E-4D24-A895-E8A2BD5F633B
Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma
P2860
Q27021470-604F05DA-0A9E-4D24-A895-E8A2BD5F633B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27021470-604F05DA-0A9E-4D24-A895-E8A2BD5F633B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e0cf961dd4147d41267ff4ba62fd817c4ef75463
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer